Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-117
Closed -$15K 452
2022
Q3
$15K Hold
117
﹤0.01% 472
2022
Q2
$16K Hold
117
﹤0.01% 454
2022
Q1
$16K Hold
117
﹤0.01% 441
2021
Q4
$20K Sell
117
-1
-0.8% -$167 ﹤0.01% 427
2021
Q3
$19K Buy
118
+1
+0.9% +$172 ﹤0.01% 421
2021
Q2
$21K Hold
117
﹤0.01% 394
2021
Q1
$23K Hold
117
﹤0.01% 378
2020
Q4
$24K Buy
+117
New +$24.2K ﹤0.01% 366
2017
Q4
Sell
-2,624
Closed -$346K 848
2017
Q3
$346K Buy
+2,624
New +$353K 0.06% 148

Other funds holding CLX

Howe & Rusling's CLX Position: Q4 2022 in Review

Howe & Rusling sold out of Clorox (CLX) in Q4 2022, closing a stake of 117 shares — an estimated $15K sold.

Howe & Rusling first reported a position in CLX in Q3 2017 and held it in 9 quarters. The position peaked at $346K in Q3 2017. 1,105 funds tracked by Wall St. Rank hold CLX as of Q4 2022.

  • Howe & Rusling reported no remaining Clorox position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 117 Clorox shares in Q4 2022, an estimated $15K.
  • Howe & Rusling first reported a position in Clorox in Q3 2017 and held it in 9 quarters.
  • Howe & Rusling's Clorox position peaked at $346K in Q3 2017.
  • 1,105 funds tracked by Wall St. Rank held Clorox as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.